US equities |
MU $1,097.39 ▲+3.03% NVDA $230.86 ▲+1.09% SNDK $1,787.69 ▲+2.75% INTC $120.00 ▼-0.19% AAPL $330.32 ▼-0.81% GOOGL $338.24 ▼-1.70% TSLA $354.11 ▼-0.20% AMD $615.73 ▲+0.65%
FinancialContent

Articles published by SOLVE FSHD

News headline image
SOLVE FSHD Accelerates Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD
From SOLVE FSHD
Via Business Wire
News headline image
SOLVE FSHD Announces Recent Grant Awards to Accelerate Treatments for Facioscapulohumeral Muscular Dystrophy
From SOLVE FSHD
Via Business Wire
News headline image
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
From SOLVE FSHD
Via Business Wire
News headline image
SOLVE FSHD Announces $3 Million Investment in Armatus Bio to Advance Gene Therapy Program for FSHD
From SOLVE FSHD
Via Business Wire
News headline image
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
From SOLVE FSHD
Via Business Wire
News headline image
SOLVE FSHD Challenges Innovators with USD$10 Million Bonus Prize to Accelerate FSHD Breakthroughs in XPRIZE Healthspan Competition
From SOLVE FSHD
Via Business Wire
News headline image
SOLVE FSHD Announces New Collaborative Research Grants to Accelerate Novel Potential Therapeutics for Facioscapulohumeral Muscular Dystrophy (FSHD)
From Solve FSHD
Via GlobeNewswire
News headline image
SOLVE FSHD invests in Epic Bio for the development of a novel treatment for Facioscapulohumeral Muscular Dystrophy
From Solve FSHD
Via GlobeNewswire
News headline image
CORRECTION -- SOLVE FSHD invests US$10 Million in Vita Therapeutics
From Solve FSHD
Via GlobeNewswire
News headline image
SOLVE FSHD invests US$10 Million in Vita Therapeutics
From Solve FSHD
Via GlobeNewswire